RK-4

· Neurodawn Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RK-4, covering 2025-09-30 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device [NA]

See pricing